J Korean Med Sci.  2004 Aug;19(4):567-573. 10.3346/jkms.2004.19.4.567.

Prologation of c-Jun N-Terminal Kinase is Associated with Cell Death Induced by Tumor Necrosis Factor Alpha in Human Chondrocytes

• Yoon HS
• Kim HA

• KMID: 2157687
• DOI: http://doi.org/10.3346/jkms.2004.19.4.567

Abstract

The aim of this study was to elucidate the role of JNK signaling pathway involved in tumor necrosis factor-alpha (TNF-alpha)-induced death of chondrocytes. Primary chondrocyte cultures were obtained from human knee osteoarthritis cartilages. First passage chondrocytes were treated with TNF-alpha and various potentiators, and cell death was measured with MTT assay. C-Jun N terminal kinase (JNK) activation was investigated with the solid phase kinase assay. Expression of apoptosis-related molecule was assayed with Western blot. Chondrocytes were resistant to TNF-alpha-induced cell death. In contrast, pretreatment with actinomycin D, the phosphatase inhibitor vanadate or MAP kinase phosphatase-1 (MKP-1) inhibitor Ro318220 invariably led to chondrocyte death. While TNF-alpha alone stimulated a single, brief JNK activity, a second JNK peak was observed when the cells were pretreated with actinomycin D. When the cells were pretreated with vanadate or Ro318220, TNF-alpha-induced JNK activation was greatly prolonged, which was associated with the induction of cell death. The expression of Bcl-2 and Mcl-1 decreased significantly in conditions of cell death. In conclusions, our data suggest that chondrocyte death induced by TNF-alpha is associated with sustained JNK activation. This effect may be due to downregulation of TNF-alpha induced phosphatase that inactivates JNK and of Bcl-2 family proteins.

Keyword

Chondrocytes; Apoptosis; Tumor Necrosis Factor; Mitogen-Activated Protein Kinases

MeSH Terms

Cell Death/*physiology
Cells, Cultured
Chondrocytes/cytology/*drug effects/metabolism
Enzyme Activation
Enzyme Inhibitors/metabolism
Humans
JNK Mitogen-Activated Protein Kinases/*metabolism
NF-kappa B/metabolism
Neoplasm Proteins/metabolism
Proto-Oncogene Proteins c-bcl-2/metabolism
Research Support, Non-U.S. Gov't
Signal Transduction/physiology
Tumor Necrosis Factor-alpha/*pharmacology

Figure

• 

  Fig. 1 Patterns of c-Jun N terminal kinase (JNK) phosphorylation in human chondrocytes after treatment with TNF-alpha with or without vanadate, Ro318220, or actinomycin D. Both vanadate and Ro318220 increase the intensity and duration of JNK phosphorylation. Actinomycin D induces prolongation of SAPK/JNK activation, yielding second activation peak at 240 min of treatment. JNK activation was assessed by solid phase kinase assay. Data are representative of samples from 3 donors.

• 

  Fig. 2 (A) Kinetics of chondrocyte death induced by 10 ng/mL of TNF-α after 1 hr pretreatment with 500 µM vanadate or 10 µM Ro318220. Cell death increases significantly after 12 hr of treatment detected by MTT assay. Cell survival in control culture was set at 100%. Asterisks denote p<0.05. Data are means from samples from 6 donors. (B) Chondrocyte apoptosis is verified by quantitation of subdiploid cells analyzed with flow cytometry. Cells were fixed with 70% ethanol 24 hr after TNF-α treatment and stained with propidium iodide before analysis with flow cytometry. Numbers denote percent subdiploid cells. Data are representative of samples from 4 donors. (C) Annexin V-FITC/propidium iodide (PI) dual staining of chondrocytes analyzed by flow cytometry. Cells were stained 12 hr after TNF-α treatment. Numbers in the right lower quadrant denotes percentages of early apoptotic chondrocytes (annexin V positive, PI negative). Data are representative of 3 samples from different donors. (D) Processing of caspase-3 revealed by Western blot. Cells were treated with TNF-α for 6 hr and lysates were assayed for caspase-3. T: TNF-alpha, VT: vanadate pretreatment followed by TNF-alpha, RT: Ro318220 pretreatment followed by TNF-α . Arrow denotes processed caspase-3 band. Data are representative of samples from 3 donors. (E) Chondrocyte death induced by TNF-alpha and 500 µM vanadate or 10 µM Ro318220 is effectively inhibited by pan-caspase inhibitor, zVAD -FMK, implicating the involvement of caspase cascade. Cell death was measured by MTT assay, and the degree of cell death after 24 hr of incubation without zVAD-FMK was set at 100%. Asterisks denote p<0.05. Data are means from samples from 5 donors.

• 

  Fig. 3 (A) The influence of vanadate and Ro318220 on NF-κB activation induced by TNF-alpha in human articular chondrocyte. Nuclear extract was prepared 15 min after treatment with 10 ng/mL of TNF-alpha, and electrophoretic mobility shift assay was performed. Data are representative of samples from 3 donors. (B) Western blot for IκB of cytosolic extract of the same set of samples as in (A). (C) Western blot for phosphorylated IκB of cytosolic extract of the same set of samples as in (A).

• 

  Fig. 4 Patterns of Mcl-1 and Bcl-2 expression after TNF-alpha treatment with or without vanadate, or Ro318220. Twenty microgram of proteins were separated in SDS-PAGE gel and probed with respective antibodies. T, TNF-alpha; VT, vanadate pretreatment followed by TNF-alpha; RT, Ro318220 pretreatment followed by TNF-alpha. Data are representative of samples from 3 donors.

Reference

1. Kim HA, Song YW. Apoptotic chondrocyte death in rheumatoid arthritis. Arthritis Rheum. 1999. 42:1528–1537.

2. Blanco FJ, Guitian R, Vazquez-Martul E, de Toro FJ, Galdo F. Osteoarthritis chondrocytes die by apoptosis: A possible pathway for osteoarthritis pathology. Arthritis Rheum. 1998. 41:284–289.

3. Ishizaki Y, Burne JF, Raff MC. Autocrine signals enable chondrocytes to survive in culture. J Cell Biol. 1994. 126:1069–1077.

4. Hashimoto S, Setareh M, Ochs RL, Lotz M. Fas/Fas ligand expression and induction of apoptosis in chondrocytes. Arthritis Rheum. 1997. 40:1749–1755.

5. Blanco FJ, Ochs RL, Schwarz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol. 1995. 146:75–85.

6. Baker SJ, Reddy EP. Modulation of life and death by the TNF receptor superfamily. Oncogene. 1998. 17:3261–3270.

7. Westacott CI, Atkins RM, Dieppe PA, Elson CJ. Tumor necrosis factor-alpha receptor expression on chondrocytes isolated from human articular cartilage. J Rheumatol. 1994. 21:1710–1715.

8. Kim HA, Song YW. TNF-alpha-mediated apoptosis in chondrocytes sensitized by MG132 or actinomycin D. Biochem Biophys Res Commun. 2002. 295:937–944.

9. Yoon YM, Kim SJ, Oh CD, Ju JW, Song WK, Yoo YJ, Huh TL, Chun JS. Maintenance of differentiated phenotype of articular chondrocytes by protein kinase C and extracellular signal-regulated protein kinase. J Biol Chem. 2002. 277:8412–8420.

10. Xu Y, Bialik S, Jones BE, Iimuro Y, Kitsis RN, Srinivasan A, Brenner DA, Czaja MJ. NF-kappaB inactivation converts a hepatocyte cell line TNF-alpha response from proliferation to apoptosis. Am J Physiol. 1998. 275:C1058–C1066.

11. Schreiber E, Matthias P, Muller MM, Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts' prepared from a small number of cells. Nucleic Acids Res. 1989. 17:6419.

12. Guo YL, Baysal K, Kang B, Yang LJ, Williamson JR. Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. J Biol Chem. 1998. 273:4027–4034.

13. Guo YL, Kang B, Williamson JR. Inhibition of the expression of mitogen-activated protein phosphatase-1 potentiates apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. J Biol Chem. 1998. 273:10362–10366.

14. Hsu H, Huang J, Shu HB, Baichwal V, Goeddel DV. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity. 1996. 4:387–396.

15. Relic B, Bentires-Alj M, Ribbens C, Franchimont N, Guerne PA, Benoit V, Merville MP, Bours V, Malaise MG. TNF-alpha protects human primary articular chondrocytes from nitric oxide-induced apoptosis via Nuclear Factor-kappaB. Lab Invest. 2002. 82:1661–1672.

16. Kyriakis JM, Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem. 1996. 271:24313–24316.

17. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 1995. 270:1326–1331.

18. Chen YR, Wang X, Templeton D, Davis RJ, Tan TH. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J Biol Chem. 1996. 271:31929–31936.

19. Zanke BW, Boudreau K, Rubie E, Winnett E, Tibbles LA, Zon L, Kyriakis J, Liu FF, Woodgett JR. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat. Curr Biol. 1996. 6:606–613.

20. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, Kolesnick RN. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature. 1996. 380:75–79.

21. Goillot E, Raingeaud J, Ranger A, Tepper RI, Davis RJ, Harlow E, Sanchez I. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc Natl Acad Sci USA. 1997. 94:3302–3307.

22. Natoli G, Costanzo A, Ianni A, Templeton DJ, Woodgett JR, Balsano C, Levrero M. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science. 1997. 275:200–203.

23. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 1998. 281:1680–1683.

24. Lamb JA, Ventura JJ, Hess P, Flavell RA, Davis RJ. JunD mediates survival signaling by the JNK signal transduction pathway. Mol Cell. 2003. 11:1479–1489.

25. Kim HA, Kim YH, Song YW. Facilitation of Fas mediated apoptosis of human chondrocytes by the proteasome inhibitor and actinomycin D. J Rheumatol. 2003. 30:550–558.

26. Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, Karin M, Lin A. Inhibition of JNK activation through NF-kappaB target genes. Inhibition of JNK activation through NF-kappaB target genes. Nature. 2001. 414:313–317.

27. Molton SA, Todd DE, Cook SJ. Selective activation of the c-Jun N-terminal kinase (JNK) pathway fails to elicit Bax activation or apoptosis unless the phosphoinositide 3'-kinase (PI3K) pathway is inhibited. Oncogene. 2003. 22:4690–4701.

28. Pei XY, Dai Y, Grant S. The proteasome inhibitor bortezomib promotes mitochondrial injury and apoptosis induced by the small molecule Bcl-2 inhibitor HA14-1 in multiple myeloma cells. Leukemia. 2003. 17:2036–2045.